MarketResearch.biz delivers in-depth insights on the global pediatric vaccines market in its upcoming report titled, “Global Pediatric Vaccines Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global pediatric vaccines market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global pediatric vaccines market report has been segmented on the basis of vaccine type, technique, disease, and region.
Pediatric vaccine helps infant, children to develop immune system to fight against serious infections and diseases. It is given to children with an age group of 0-18 years. Vaccination starts from early stage of life which helps children to protect from several infectious diseases. Pediatric vaccination has made many serious childhood diseases rare. Rotavirus causes diarrhea in children, the rotavirus vaccine project against rotavirus.
Increasing awareness about the benefits associated with vaccination in preventing diseases globally is expected to fuel the growth of global pediatric vaccines market over the forecast period. Moreover, several government and non-profit organizations providing education, funding and support services for vaccines is anticipated to further drive growth of the global pediatric vaccines market over the forecast period. Increasing number of cases of influenza, hepatitis, bacterial and viral infection in infant, children and increasing birth rate globally is expected to fuel the market demand over the forecast period.
Stringent government regulations for approval process and high cost involved with the development of vaccines are major factor restraining the growth of pediatric vaccines market over the forecast period.
However, technological advancements and innovations focusing on development of pediatric vaccines with high efficiency and low cost is expected to create new opportunities for existing as well as new market entrant in the global pediatric vaccines market over the forecast period.
North America market dominates the global pediatric vaccines market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of well-developed healthcare infrastructure and presence of dominant players in the region. Europe accounts for second-largest revenue share contribution to the global pediatric vaccines market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Europe is projected to register comparatively faster growth in terms of revenue over the next 10 years owing increasing incidence of diseases such hepatitis, pneumococcal disease, and influenza in the region.
Global pediatric vaccines market segmentation;
By vaccine type:
- Monovalent Vaccines
- Multivalent Vaccines
- Live Attenuated
- Recombinant Vector Vaccine
- Measles, Mumps, and rubella (MMR)
- Pneumococcal disease
- Meningococcal disease
- Diphtheria, Tetanus, and Pertussis (DTP)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- GlaxoSmithKline Plc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi SA
- Indian Immunologicals Ltd.
- Serum Institute of India Pvt. Ltd
- Panacea Biotec Limited
- Sinovac Biotech Ltd.
- Bio Med Pvt. Ltd.
- Zydua Cadila
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!